Display options
Share it on

BMC Proc. 2018 Sep 17;12:22. doi: 10.1186/s12919-018-0118-9. eCollection 2018.

Direct and indirect genetic effects on triglycerides through omics and correlated phenotypes.

BMC proceedings

Anne E Justice, Annie Green Howard, Lindsay Fernández-Rhodes, Misa Graff, Ran Tao, Kari E North

Affiliations

  1. 1Department of Epidemiology, University of North Carolina, Chapel Hill, NC USA.
  2. 2Biomedical and Translational Informatics, Geisinger Health, Danville, PA USA.
  3. 3Department of Biostatistics, University of North Carolina, Chapel Hill, NC USA.
  4. 4Carolina Population Center, University of North Carolina, Chapel Hill, NC USA.
  5. 5Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN USA.

PMID: 30275878 PMCID: PMC6157130 DOI: 10.1186/s12919-018-0118-9

Abstract

Even though there has been great success in identifying lipid-associated single-nucleotide polymorphisms (SNPs), the mechanisms through which the SNPs act on each trait are poorly understood. The emergence of large, complex biological data sets in well-characterized cohort studies offers an opportunity to investigate the genetic effects on trait variability as a way of informing the causal genes and biochemical pathways that are involved in lipoprotein metabolism. However, methods for simultaneously analyzing multiple omics, environmental exposures, and longitudinally measured, correlated phenotypes are lacking. The purpose of our study was to demonstrate the utility of the structural equation modeling (SEM) approach to inform our understanding of the pathways by which genetic variants lead to disease risk. With the SEM method, we examine multiple pathways directly and indirectly through previously identified triglyceride (TG)-associated SNPs, methylation, and high-density lipoprotein (HDL), including sex, age, and smoking behavior, while adding in biologically plausible direct and indirect pathways. We observed significant SNP effects (

Conflict of interest statement

Not applicable.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affilia

References

  1. Curr Opin Lipidol. 2015 Apr;26(2):133-8 - PubMed
  2. Clin Epigenetics. 2017 Feb 7;9:15 - PubMed
  3. Am J Hum Genet. 2013 Jun 6;92(6):904-16 - PubMed
  4. J Med Genet. 2009 Jul;46(7):472-9 - PubMed
  5. Nat Commun. 2014 Jun 02;5:3983 - PubMed
  6. Nat Genet. 2008 Feb;40(2):161-9 - PubMed
  7. J Med Genet. 2013 May;50(5):298-308 - PubMed
  8. Nature. 2010 Aug 5;466(7307):707-13 - PubMed
  9. PLoS Genet. 2009 Nov;5(11):e1000730 - PubMed
  10. Sci Rep. 2016 Jan 19;6:19429 - PubMed
  11. J Lipid Res. 2011 Feb;52(2):189-206 - PubMed
  12. Psychol Bull. 1990 Mar;107(2):238-46 - PubMed
  13. J Lipid Res. 2016 Dec;57(12):2185-2192 - PubMed
  14. Nat Genet. 2009 Jan;41(1):47-55 - PubMed
  15. PLoS Genet. 2011 Jun;7(6):e1002138 - PubMed
  16. Ann Hum Genet. 2011 Mar;75(2):255-65 - PubMed
  17. PLoS One. 2012;7(12):e51954 - PubMed
  18. PLoS Genet. 2006 Jul;2(7):e114 - PubMed
  19. Nat Genet. 2013 Nov;45(11):1274-1283 - PubMed

Publication Types

Grant support